The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The Trump administration dismissed members of the Environmental Protection Agency’s (EPA) Clean Air Scientific Advisory Committee and Science Advisory Board on Tuesday, a day before the ...

Kennedy Jr., Trump's pick for HHS secretary. However, it remains unclear how much could actually change if Kennedy were to be ...

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

W ith respiratory-disease season in full swing and a bird flu outbreak rapidly evolving, the new Trump Administration has ...

With numerous day trading chart providers available in the market, choosing the right one can be a daunting task. To assist you in this endeavor, Benzinga has compiled a comparison list of some of ...

It’s been more than three years since DBV Technologies’ peanuty allergy therapy was rejected for FDA approval, but the company thinks it now has a clear route to market with its patch product ...

A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...